
Region:Global
Author(s):Paribhasha Tiwari
Product Code:KROD6260
November 2024
80



The global hernia repair market is characterized by the presence of both global and regional players. Key companies are investing in research and development to improve surgical outcomes and enhance the biocompatibility of hernia repair products. The market is also witnessing significant consolidation through mergers and acquisitions, highlighting the influence of key players in shaping market dynamics.
|
Company |
Establishment Year |
Headquarters |
R&D Spending |
Geographical Presence |
Key Products |
No. of Hernia Repair Surgeries Supported |
Patent Portfolio |
Collaborations |
FDA Approvals |
|
Medtronic Plc |
1949 |
Dublin, Ireland |
- | - | - | - | - | - | - |
|
Johnson & Johnson (Ethicon) |
1886 |
New Brunswick, USA |
- | - | - | - | - | - | - |
|
B. Braun Melsungen AG |
1839 |
Melsungen, Germany |
- | - | - | - | - | - | - |
|
Cook Medical |
1963 |
Bloomington, USA |
- | - | - | - | - | - | - |
|
W.L. Gore & Associates |
1958 |
Newark, USA |
- | - | - | - | - | - | - |
Over the next five years, the global hernia repair market is expected to experience robust growth driven by continuous advancements in minimally invasive techniques, a rising geriatric population, and increasing cases of hernias worldwide. Technological innovations, particularly in biologic mesh and robotic-assisted surgeries, will play a significant role in enhancing patient outcomes and reducing recovery times. Moreover, expanding healthcare access in emerging markets and government efforts to improve healthcare infrastructure are expected to create substantial growth opportunities in the market.
|
By Product Type |
Synthetic Mesh Biologic Mesh Fixation Devices Non-Mesh Hernia Repair |
|
By Procedure Type |
Laparoscopic Repair Open Repair |
|
By Surgery Type |
Inguinal Hernia Repair Incisional Hernia Repair Umbilical Hernia Repair Femoral Hernia Repair |
|
By Hernia Type |
Reducible Hernia Irreducible Hernia Strangulated Hernia |
|
By End-Use |
Hospitals Ambulatory Surgical Centers Clinics |
1.1. Definition and Scope
1.2. Market Taxonomy
1.3. Market Growth Rate (Hernia Procedures, Regional Demand, Healthcare Accessibility)
1.4. Market Segmentation Overview (By Product Type, Procedure Type, Surgery Type, Hernia Type, End-Use)
2.1. Historical Market Size
2.2. Year-On-Year Growth Analysis
2.3. Key Market Developments and Milestones (Surgical Innovations, FDA Approvals)
3.1. Growth Drivers
3.1.1. Rise in Hernia Procedures (Clinical Data on Hernia Prevalence, Aging Population)
3.1.2. Advancements in Surgical Techniques (Laparoscopic and Robotic Procedures)
3.1.3. Increased Adoption of Synthetic Mesh (FDA-Approved Mesh Products, Innovation in Biocompatibility)
3.1.4. Government Healthcare Reimbursement Policies (Policy Changes in Key Regions)
3.2. Market Challenges
3.2.1. High Cost of Hernia Repair Surgeries (Cost Constraints in Developing Economies)
3.2.2. Post-Surgery Complications (Recurrence Rates, Mesh Rejection)
3.2.3. Stringent Regulatory Approvals (FDA, EMA Compliance and Approvals)
3.2.4. Limited Access to Advanced Medical Facilities (Rural and Low-Income Areas)
3.3. Opportunities
3.3.1. Growing Demand for Minimally Invasive Surgeries (Technological Adoption in Emerging Markets)
3.3.2. Rising Preference for Biologic Mesh Products (Biocompatibility, Reduced Rejection Rates)
3.3.3. Medical Tourism Opportunities (Cost Advantages in Emerging Economies)
3.3.4. Expansion of Hernia Repair Techniques in Ambulatory Surgical Centers (Outpatient Care Adoption)
3.4. Trends
3.4.1. Robotic-Assisted Hernia Repair Surgeries (Market Penetration of Robotic Systems)
3.4.2. Increased Focus on Post-Surgical Care (Mesh Innovations to Reduce Recurrence)
3.4.3. Growth in Laparoscopic Hernia Repair (Adoption in Urban Hospitals)
3.4.4. Expansion of Single-Incision Hernia Repair (Key Market Adoption, Surgeon Training)
3.5. Government Regulation
3.5.1. Surgical Mesh Regulation (FDA Guidelines on Mesh Safety)
3.5.2. Surgical Device Registration and Compliance (Country-Specific Guidelines)
3.5.3. Reimbursement Policies and Government Support (Medicare, Medicaid Coverage)
3.5.4. Clinical Trials and Data Requirements (Pre-Market Approvals for New Devices)
3.6. SWOT Analysis
3.7. Stake Ecosystem
3.8. Porters Five Forces
3.9. Competition Ecosystem
4.1. By Product Type (In Value %)
4.1.1. Synthetic Mesh
4.1.2. Biologic Mesh
4.1.3. Fixation Devices
4.1.4. Non-Mesh Hernia Repair
4.2. By Procedure Type (In Value %)
4.2.1. Laparoscopic Repair
4.2.2. Open Repair
4.3. By Surgery Type (In Value %)
4.3.1. Inguinal Hernia Repair
4.3.2. Incisional Hernia Repair
4.3.3. Umbilical Hernia Repair
4.3.4. Femoral Hernia Repair
4.4. By Hernia Type (In Value %)
4.4.1. Reducible Hernia
4.4.2. Irreducible Hernia
4.4.3. Strangulated Hernia
4.5. By End-Use (In Value %)
4.5.1. Hospitals
4.5.2. Ambulatory Surgical Centers
4.5.3. Clinics
5.1. Detailed Profiles of Major Companies
5.1.1. Medtronic Plc
5.1.2. Johnson & Johnson (Ethicon)
5.1.3. B. Braun Melsungen AG
5.1.4. Cook Medical
5.1.5. C.R. Bard (Becton Dickinson)
5.1.6. W.L. Gore & Associates
5.1.7. Stryker Corporation
5.1.8. Herniamesh Srl
5.1.9. Integra Lifesciences
5.1.10. Cousin Biotech
5.1.11. Lifecell Corporation
5.1.12. TELA Bio, Inc.
5.1.13. Atrium Medical Corporation
5.1.14. Betatech Medical
5.1.15. Baxter International Inc.
5.2. Cross Comparison Parameters (R&D Spending, Product Portfolio, Patent Ownership, Geographical Presence, FDA Approvals, Revenue, Surgical Outcomes, Number of Collaborations)
5.3. Market Share Analysis
5.4. Strategic Initiatives (Partnerships, Joint Ventures)
5.5. Mergers And Acquisitions
5.6. Investment Analysis
5.7. Venture Capital Funding
5.8. Government Grants
5.9. Private Equity Investments
6.1. Surgical Device Safety Standards
6.2. Mesh Product Approval Processes
6.3. Compliance Requirements for Hernia Repair Devices
6.4. Regional Guidelines and Certification Processes
7.1. Future Market Size Projections
7.2. Key Factors Driving Future Market Growth
8.1. By Product Type (In Value %)
8.2. By Procedure Type (In Value %)
8.3. By Surgery Type (In Value %)
8.4. By Hernia Type (In Value %)
8.5. By End-Use (In Value %)
9.1. TAM/SAM/SOM Analysis
9.2. Customer Cohort Analysis
9.3. Marketing Initiatives
9.4. White Space Opportunity Analysis
The initial phase involves mapping the ecosystem of the global hernia repair market, identifying major stakeholders such as medical device manufacturers, surgeons, and healthcare institutions. Through extensive desk research, we analyze the historical data and establish key variables such as technological advancements and product innovation.
In this phase, we compile data on hernia repair procedures performed globally, assessing adoption rates of synthetic vs. biologic mesh and evaluating procedure-specific costs. Additionally, healthcare accessibility and the regulatory landscape are considered to assess market barriers.
Market assumptions are validated by consulting industry experts, including medical device manufacturers and surgeons specializing in hernia repair. Expert feedback provides critical insights into product efficacy, safety concerns, and market adoption trends.
The final phase integrates quantitative and qualitative data derived from primary and secondary sources, producing a comprehensive and validated report on the global hernia repair market. This ensures accuracy and reliability in all insights presented.
The global hernia repair market is valued at USD 4 billion, driven by a growing number of hernia procedures and advancements in surgical technologies.
Challenges in the global hernia repair market include high costs associated with hernia repair surgeries, post-surgery complications like mesh rejection, and stringent regulatory hurdles for new products.
Key players in the global hernia repair market include Medtronic Plc, Johnson & Johnson (Ethicon), B. Braun Melsungen AG, Cook Medical, and W.L. Gore & Associates. These companies lead due to their strong product portfolios and market presence.
Key drivers in the global hernia repair market include a rise in hernia procedures worldwide, increased adoption of synthetic and biologic mesh products, and advancements in minimally invasive and robotic surgeries.
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.